Competidores
Simbolo bursátil | Precio | Pronóstico 1A | Pronóstico 2A | Cap. Mercado | Div Yld | Tasa de crecimiento |
---|---|---|---|---|---|---|
NYSE:JNJ
Johnson & Johnson
|
146.14 | 0% | 0% | 356,431.01 | 3.39% | 3.91% |
NYSE:MRK
Merck
|
131.20 | -7.08% | 6.52% | 321,694.58 | 2.35% | -19.03% |
LSE:AZN
AstraZeneca PLC
|
119.88 | 19.74% | 42.63% | 186,430.79 | 2.08% | 15.98% |
NYSE:PFE
Pfizer
|
25.40 | 19.53% | 52.98% | 147,226.07 | 6.61% | -9.31% |
ENXTPA:SAN
Sanofi
|
91.23 | 21.11% | 40.45% | 109,506.23 | 4.12% | 8.19% |
LSE:GSK
GSK
|
16.53 | 15.36% | 32.47% | 67,542.62 | 3.51% | 0.79% |
SWX:LONN
Lonza Group
|
527.80 | -27.63% | -12.41% | 37,702.55 | 0.76% | 0.68% |
TSE:4502
Takeda Pharmaceutical Company
|
4089.00 | 0% | 0% | 6,383,951.56 | 4.6% | 0% |
NasdaqGS:MRNA
Moderna
|
107.97 | -,114.04% | -,109.69% | 38,827.82 | 0% | 0% |
ENXTPA:VLA
Valneva
|
3.44 | 0% | 0% | 528.64 | 0% | 0% |
NasdaqGM:CVAC
CureVac N.V.
|
2.33 | 0% | 0% | 562.05 | 0% | 0% |
NasdaqGS:NVAX
Novavax
|
4.09 | 0% | 0% | 555.61 | 0% | 0% |
NasdaqCM:VBIV
VBI Vaccines
|
0.57 | 0% | 0% | 18.02 | 0% | 0% |